I believe with so called &quot;Orphan diseases&quot; the economics of research and eventual market release rarely work out for private companies. I believe it takes a research phase funded by charities, grants, and tax breaks for companies to have any interest.  As a family affected by this, whatever gets this to market.  However, I am sure someone will make money.